Evaluating PSMA PET/CT Imaging for Prostate Cancer Patients
Official title: Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
Run by Tianjin Medical University · NCT06690970 · Data updated 2026-11-12
This study is testing a special type of imaging called PSMA PET/CT to see if it can help find cancer in adults who have or might have prostate cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Tianjin Medical University Academic / other |
| Locations | 3 sites (Hefei, Anhui and 2 other locations) |
| Status | Recruiting |
| Started | September 1, 2020 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | September 8, 2026 |
| Trial ID | NCT06690970 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients with suspected or newly diagnosed malignant tumors who are scheduled for a PSMA PET/CT scan.
✕Probably not a fit
Patients with non-malignant lesions or those who are pregnant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of 68Ga/18F-PSMA positron emission tomography/computed tomography (PET/CT) in diagnosing primary and metastatic lesions in patients with PSMA-related diseases. Participants, who are adults with suspected or diagnosed malignant tumors, undergo PET/CT scans to assess the presence of cancerous lesions. The study measures various diagnostic metrics, including sensitivity and specificity, to determine the imaging technique's accuracy in identifying cancer. The findings aim to enhance diagnostic capabilities for prostate cancer and related conditions.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of diagnosing prostate cancer and its metastases, leading to better treatment decisions.
How similar studies have gone: Other studies have shown promising results with similar imaging approaches, indicating potential for success in this area.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- (i) adult patients (aged 18 years or order); (ii) patients with suspected or new diagnosed or previously treated malignant tumors (supporting evidence may include MRI, CT, tumor markers and pathology report); (iii) patients who had scheduled PSMA PET/CT scan; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee. Exclusion Criteria: \- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Where it's running
-
The First Affiliated Hospital of University of Science and Technology of China
Hefei, Anhui, China Recruiting -
The Affiliated Hospital of Qingdao University
Qingdao, Shandong, China Recruiting -
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, China Recruiting
Study contacts
- Study coordinator: Haonan Yu, MD
- Email: dreamadam@126.com
- Phone: +8613821000597
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Dose-finding of EXS74539 (REC-4539) in select solid tumors
This study will try different doses of the experimental drug EXS74539 in adults with select solid tumors to find a safe and tolerable dose.
-
Evaluating radiation dose effects in prostate cancer treatment with 177Lu-PSMA-617
This study is testing how much radiation is given to tumors and nearby organs in patients with advanced prostate cancer who are being treated with a specific drug called 177Lu-PSMA-617.
-
Evaluating PET/CT for SSTR-related diseases
This study is testing a new type of PET/CT scan to see if it can help find cancer spots in adults who have tumors related to SSTR diseases.
-
Imaging CXCR4-related diseases using PET/CT
This study is testing a new type of imaging to see if it can better identify and track diseases related to CXCR4 in patients.
-
Evaluating FAPI PET/CT for Diagnosing FAP-Related Diseases
This study is testing if a special type of scan can help find cancer in adults who have or might have tumors related to FAP.
-
Imaging with 68Ga-PSFA in patients with specific cancer markers
This study is testing a new imaging agent to see if it can help find cancer spots in patients with certain cancer markers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.